About: Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2000 (uk) im Oktober 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2000 (ast) scientific article published on 01 October 2000 (en)
publication date	wds:Q73086312-68BA74F6-ACCA-4703-9D37-6E89091E8683
publication date	2000-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73086312-3835BA2F-5D33-4CB6-9711-030BA3EAEF53
language of work or name	English
cites work	wds:Q73086312-3B7F3363-C855-417E-8D4F-174F90870352
cites work	Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.
author name string	wds:Q73086312-0396F0CB-23A0-40AF-8992-9050DCB3B3F4 wds:Q73086312-04B05C89-C1E1-4367-BC47-81A51716033F wds:Q73086312-B0FBA29B-93F5-4BCE-9F6C-EBBFB5D1F083
author name string	F A Lemonnier M L Michel D Loirat
rdfs:label	Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization (en) Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization (nl)
skos:prefLabel	Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization (en) Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization (nl)
name	Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization (en) Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization (nl)
title	wds:Q73086312-6568B9D3-BF53-474F-A556-AB1F16AC947B
title	Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization (en)
page(s)	wds:Q73086312-C791A8DE-2072-4605-B3A1-910E4B91BA7D
page(s)	4748-4755
instance of	wds:Q73086312-B178222D-5426-45EF-A70F-5D7E108D3889
instance of	scholarly article
main subject	wds:Q73086312-177F58DC-0334-4636-944D-9D55068EDF2E
main subject	hepatitis B
PubMed ID	wds:Q73086312-9DF89CE3-E2B2-4A49-BAC7-683D1A21BCFF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11035120
PubMed ID	11035120
published in	wds:Q73086312-FDBDEF00-0833-4A18-B288-4CF0F59E5EE6
published in	Journal of Immunology
issue	wds:Q73086312-AFF8486D-3FE1-48AC-B272-6901BCA75E7D
volume	wds:Q73086312-246E2CC6-9CC8-43EB-A70A-BF5F2E293803
issue	8
volume	165
DOI	wds:Q73086312-9AF0E0E0-B904-420F-B549-6B5BE20C0F60
DOI	http://dx.doi.org/10.4049/JIMMUNOL.165.8.4748
DOI	10.4049/JIMMUNOL.165.8.4748
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73086312
is cites work of	Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A0201 transgenic, H-2 class I KO mice HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1 Hepatitis B virus (HBV)-derived DRB10101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses Refinement of strategies for the development of a human cytomegalovirus dense body vaccine. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end? Towards immunotherapy for chronic hepatitis B virus infections Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use. A novel mouse model for immunogenic evaluation of human HBV vaccines
is cites work of	wds:Q34988328-36735A38-35A7-4789-A954-D4F4B400AA93 wds:Q35242814-AA1AD167-FEA0-4074-B3BF-BA9BCC0656C6 wds:Q44264951-18A3439F-0E71-4BC1-AF37-AD72E05A59C2 wds:Q80828494-C46BC61F-26E9-4C4D-A942-40F0E47817A4 wds:Q34342982-F70F5B57-C1E6-459B-8C05-BE06E5FE4FB2 wds:Q45599234-2C88A465-4965-45E7-B50E-E76A8D741D69 wds:Q51724569-AC8C0AE2-F843-4CC6-9C80-118CB4D82F0C wds:Q81128868-2E44ECA3-DDD5-400D-9298-7A4CF5FB4733 wds:Q38749284-53FE6036-C57C-4E1F-82EC-C54259658B55 wds:Q28076279-7150EF5C-2707-419F-AFE9-F0AABCF78081 wds:Q45377063-A4F14601-897F-41B9-AE22-798195D8C378 wds:Q80445239-08320767-D5A6-4949-9352-28B3438ABBA7 wds:Q33525552-2EE7073D-8203-4879-ADFB-EB82C1446A8B wds:Q38289734-0AC4989A-2B38-4B7F-9A1C-EF86445B0FFE wds:Q36506285-FF880652-BAF0-4AF5-88E8-5100C4EF927B wds:Q39789227-B2CF2FE7-916A-40BC-AB98-C5D078A6C0D8 wds:Q40089302-638215D1-7353-46F6-8AC8-7C0DCE315500

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software